Based on our cutting-edge immunological research and findings, Edelweiss Immune is dedicated to developing novel therapeutics with better selectivity, safety, and efficacy for patients suffering autoimmune diseases such as multiple sclerosis, inflammatory arthritis, and psoriasis.
Dr. Eileen Remold-O’Donnell and Dr. Lifei Hou
